Alternative treatment method for novel coronavirus disease 2019: Coupled plasma filtration adsorption

dc.authorid0000-0002-3245-6614
dc.authorid0000-0002-5715-8138
dc.authorid0000-0001-6587-8103
dc.authorid0000-0002-5580-5960
dc.authorid0000-0002-9815-1848
dc.authorid0000-0001-9928-9956
dc.contributor.authorÇiftçi, Bahadır
dc.contributor.authorErdoğan, Cem
dc.contributor.authorKızılaslan, Deniz
dc.contributor.authorEkinci, Mürsel
dc.contributor.authorOlmuşçelik, Oktay
dc.contributor.authorAtalay, Yunus Oktay
dc.date.accessioned2021-07-02T06:35:15Z
dc.date.available2021-07-02T06:35:15Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Anesteziyoloji ve Reanimasyon Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractDear editor: Patients infected with severe acute respiratory syndrome corona virus 2 may have mild symptoms such as fever and cough in the early stage of this disease and these symptoms may deteriorate to acute respiratory distress syndrome, multiple-organ failure, and death in the late phase.1 It has been reported that the cytokine levels increase and damage the tissues.2 As some agents used to decrease cytokine levels such as intravenous immunoglobulin and selective cytokine blockade (eg, anakinra or tocilizumab) may cause adverse events (infections, allergic reactions, and changes in blood pressure), there is a need of alternative treatment methods.3 Herein, we present our coupled plasma filtration adsorption (CPFA) (a detoxification system combining a plasma adsorption circuit) with a continuous renal replacement therapy (CRRT) experiences to treat 2 patients with coronavirus disease (COVID-19) in our tertiary university hospital intensive care unit (ICU).
dc.identifier.citationÇiftçi, B., Erdoğan, C., Kızılaslan, D., Ekinci, M., Olmuşçelik, O. ve Atalay, Y. O. (2021). Alternative treatment method for novel coronavirus disease 2019: Coupled plasma filtration adsorption. Eurasian Journal of Medicine, 53(2), 158-159. https://dx.doi.org/10.5152/eurasianjmed.2021.20151
dc.identifier.doi10.5152/eurasianjmed.2021.20151
dc.identifier.endpage159
dc.identifier.issn1308-8742
dc.identifier.issue2
dc.identifier.scopusqualityQ3
dc.identifier.startpage158
dc.identifier.urihttps://dx.doi.org/10.5152/eurasianjmed.2021.20151
dc.identifier.urihttps://hdl.handle.net/20.500.12511/7425
dc.identifier.volume53
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofEurasian Journal of Medicineen_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCoronavirus Disease
dc.subjectTreatment Method
dc.subjectPlasma Filtration Adsorption
dc.titleAlternative treatment method for novel coronavirus disease 2019: Coupled plasma filtration adsorption
dc.typeLetter

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Ciftcii-Bahadir-2021.pdf
Boyut:
111.98 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: